المؤلفون: Mario Mandalà, Juliette Murris, Paola Queirolo, Ana Arance, Caroline Dutriaux, Helen Gogas, Gabriella Liszkay, Ralf Gutzmer, Claus Garbe, Keith T. Flaherty, Abir Tadmouri Sellier, Naoya Yamazaki, Jeanne Suissa, Ivana Krajsová, Vanna Chiarion Sileni, Caroline Robert, Reinhard Dummer, Groot Jan de Willem, Paolo A. Ascierto, Ashwin Gollerkeri, Carmen Loquai, Dirk Schadendorf

المساهمون: University of Zurich

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Skin Neoplasms, Health-related quality of life, Medizin, Hospitalisation rate, chemistry.chemical_compound, 0302 clinical medicine, Quality of life, Antineoplastic Combined Chemotherapy Protocols, Vemurafenib, Melanoma, Aged, 80 and over, Sulfonamides, 10177 Dermatology Clinic, Binimetinib, Middle Aged, Progression-Free Survival, humanities, Oncology, Tolerability, 030220 oncology & carcinogenesis, Female, Open label, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, 610 Medicine & health, BRAF(V600E−K) mutant Melanoma, Young Adult, 03 medical and health sciences, BRAF/MEK inhibitors Combination, Internal medicine, medicine, Humans, In patient, Encorafenib plus binimetinib, Aged, business.industry, Repeated measures design, medicine.disease, 030104 developmental biology, chemistry, Mutation, Quality of Life, Benzimidazoles, Carbamates, business

وصف الملف: 898_Gogas_H._et_al._Quality_of_life_in_patients_with_BRAF_mutant_melanoma_receiving_the_combination_encorafenib_plus_binimetinib_EJC_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b598bc6b0d5210f8adf8a69fd7b47bTest
https://www.zora.uzh.ch/id/eprint/203982Test/

المؤلفون: Gogas, Helen, Dummer, Reinhard, Ascierto, Paolo A, Arance, Ana, Mandala', Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsová, Ivana, Gutzmer, Ralf, Sileni, Vanna Chiarion, Dutriaux, Caroline, Yamazaki, Naoya, Loquai, Carmen, Queirolo, Paola, Jan de Willem, Groot, Sellier, Abir Tadmouri, Suissa, Jeanne, Murris, Juliette, Gollerkeri, Ashwin, Robert, Caroline, Flaherty, Keith T

المساهمون: Gogas, Helen, Dummer, Reinhard, Ascierto, Paolo A, Arance, Ana, Mandala', Mario, Liszkay, Gabriella, Garbe, Clau, Schadendorf, Dirk, Krajsová, Ivana, Gutzmer, Ralf, Sileni, Vanna Chiarion, Dutriaux, Caroline, Yamazaki, Naoya, Loquai, Carmen, Queirolo, Paola, Jan de Willem, Groot, Sellier, Abir Tadmouri, Suissa, Jeanne, Murris, Juliette, Gollerkeri, Ashwin, Robert, Caroline, Flaherty, Keith T

مصطلحات موضوعية: BRAF(V600E−K) mutant Melanoma, BRAF/MEK inhibitors Combination, Encorafenib plus binimetinib, Health-related quality of life, Hospitalisation rate

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34091420; info:eu-repo/semantics/altIdentifier/wos/WOS:000678059500012; volume:152; firstpage:116-128; lastpage:128; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11391/1493907Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85107650414

الإتاحة: https://doi.org/10.1016/j.ejca.2021.04.028Test
http://hdl.handle.net/11391/1493907Test